Embryo-derived trypsin-induced calcium entry is inhibited by endometrial infertility factor, LEFTY2.

IF 4.6 2区 生物学 Q2 CELL BIOLOGY
Frontiers in Cell and Developmental Biology Pub Date : 2025-05-29 eCollection Date: 2025-01-01 DOI:10.3389/fcell.2025.1499339
Zhiqi Yang, Jing Yan, Steffen Kull, Md Alauddin, Sara Y Brucker, Melanie Henes, Florian Lang, Madhuri S Salker
{"title":"Embryo-derived trypsin-induced calcium entry is inhibited by endometrial infertility factor, LEFTY2.","authors":"Zhiqi Yang, Jing Yan, Steffen Kull, Md Alauddin, Sara Y Brucker, Melanie Henes, Florian Lang, Madhuri S Salker","doi":"10.3389/fcell.2025.1499339","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>A transient window of uterine receptivity ensures that embryos implant in an optimal endometrial environment. Failure to establish or premature closure of the implantation window is thought to be a major cause of infertility, which affects many couples globally. Embryos release trypsin, which designates its developmental potential and plays a crucial role in implantation. Calcium (Ca<sup>2+</sup>) signalling participates in receptivity and is thus a prerequisite for embryo implantation. Left-right determination factor 2 (LEFTY2) is a negative regulator of endometrial receptivity and is associated with unexplained infertility. We hypothesize that LEFTY2 impedes Ca<sup>2+</sup> entry induced by trypsin in endometrial cells.</p><p><strong>Methods: </strong><i>In silico</i> analysis was performed to investigate classical trypsin pathway genes in human embryos. Trypsin levels from single human embryo conditioned medium were subject to ELISA. To determine if trypsin signals can modulate calcium entry, intracellular calcium [Ca<sup>2+</sup>]<sub>i</sub> was determined utilizing Fura-2 fluorescence in human endometrial epithelial cells (Ishikawa cells). Bioinformatic analysis on publicly available single cell sequencing data was used to investigate the expression of <i>L-type calcium channel (CACNA1C)</i> in endometrium. qRT-PCR and immunofluorescence were used to quantify L-type calcium channel abundance.</p><p><strong>Results: </strong>We report that the trypsin machinery is established at the blastocyst stage and that high levels of trypsin are associated with a successful pregnancy. Treatment with LEFTY2 or combined treatment with LEFTY2 and trypsin blocked the increase of L-type Ca<sup>2+</sup> channel levels and activity. Treatment of endometrial cells with trypsin was followed by an increase of [Ca<sup>2+</sup>]<sub>i</sub>, an effect that was significantly blunted by amiloride and LEFTY2. Further, the trypsin induced increase of [Ca<sup>2+</sup>]<sub>i</sub> was significantly blunted by L-type calcium channel inhibitor nifedipine. In the presence of nifedipine, LEFTY2 did not further modify trypsin induced increase of [Ca<sup>2+</sup>]<sub>i</sub>. LEFTY2 significantly decreased levels of L-type Ca<sup>2+</sup> channel.</p><p><strong>Discussion: </strong>Taken together, we demonstrate that high trypsin levels are associated with a positive pregnancy outcome and that infertility factor LEFTY2 downregulates trypsin induced Ca<sup>2+</sup> increase due in part by interference with nifedipine sensitive Ca<sup>2+</sup> entry. These findings contribute further to our knowledge of unexplained infertility and failed assisted reproductive technologies.</p>","PeriodicalId":12448,"journal":{"name":"Frontiers in Cell and Developmental Biology","volume":"13 ","pages":"1499339"},"PeriodicalIF":4.6000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158927/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cell and Developmental Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fcell.2025.1499339","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: A transient window of uterine receptivity ensures that embryos implant in an optimal endometrial environment. Failure to establish or premature closure of the implantation window is thought to be a major cause of infertility, which affects many couples globally. Embryos release trypsin, which designates its developmental potential and plays a crucial role in implantation. Calcium (Ca2+) signalling participates in receptivity and is thus a prerequisite for embryo implantation. Left-right determination factor 2 (LEFTY2) is a negative regulator of endometrial receptivity and is associated with unexplained infertility. We hypothesize that LEFTY2 impedes Ca2+ entry induced by trypsin in endometrial cells.

Methods: In silico analysis was performed to investigate classical trypsin pathway genes in human embryos. Trypsin levels from single human embryo conditioned medium were subject to ELISA. To determine if trypsin signals can modulate calcium entry, intracellular calcium [Ca2+]i was determined utilizing Fura-2 fluorescence in human endometrial epithelial cells (Ishikawa cells). Bioinformatic analysis on publicly available single cell sequencing data was used to investigate the expression of L-type calcium channel (CACNA1C) in endometrium. qRT-PCR and immunofluorescence were used to quantify L-type calcium channel abundance.

Results: We report that the trypsin machinery is established at the blastocyst stage and that high levels of trypsin are associated with a successful pregnancy. Treatment with LEFTY2 or combined treatment with LEFTY2 and trypsin blocked the increase of L-type Ca2+ channel levels and activity. Treatment of endometrial cells with trypsin was followed by an increase of [Ca2+]i, an effect that was significantly blunted by amiloride and LEFTY2. Further, the trypsin induced increase of [Ca2+]i was significantly blunted by L-type calcium channel inhibitor nifedipine. In the presence of nifedipine, LEFTY2 did not further modify trypsin induced increase of [Ca2+]i. LEFTY2 significantly decreased levels of L-type Ca2+ channel.

Discussion: Taken together, we demonstrate that high trypsin levels are associated with a positive pregnancy outcome and that infertility factor LEFTY2 downregulates trypsin induced Ca2+ increase due in part by interference with nifedipine sensitive Ca2+ entry. These findings contribute further to our knowledge of unexplained infertility and failed assisted reproductive technologies.

胚胎源性胰蛋白酶诱导的钙进入受子宫内膜不育因子LEFTY2的抑制。
子宫容受性的短暂窗口确保胚胎在最佳的子宫内膜环境中植入。未能建立或过早关闭着床窗口被认为是不孕不育的主要原因,这影响了全球许多夫妇。胚胎释放胰蛋白酶,胰蛋白酶指示其发育潜力,在着床过程中起着至关重要的作用。钙(Ca2+)信号参与接受性,因此是胚胎着床的先决条件。左右决定因子2 (LEFTY2)是子宫内膜容受性的负调节因子,与不明原因的不孕症有关。我们假设LEFTY2阻碍了胰蛋白酶诱导的Ca2+进入子宫内膜细胞。方法:采用计算机分析方法对人胚胎胰蛋白酶经典通路基因进行检测。ELISA检测单个人胚胎条件培养基中胰蛋白酶水平。为了确定胰蛋白酶信号是否可以调节钙的进入,我们利用Fura-2荧光测定了人子宫内膜上皮细胞(石川细胞)的细胞内钙[Ca2+]i。利用公开的单细胞测序数据进行生物信息学分析,研究子宫内膜中l型钙通道(CACNA1C)的表达。采用qRT-PCR和免疫荧光法定量l型钙通道丰度。结果:我们报道胰蛋白酶机制在囊胚阶段建立,高水平的胰蛋白酶与成功妊娠有关。LEFTY2处理或LEFTY2与胰蛋白酶联合处理可阻断l型Ca2+通道水平和活性的增加。用胰蛋白酶处理子宫内膜细胞后,[Ca2+]i增加,这一效应被阿米洛利和LEFTY2显著减弱。此外,l型钙通道抑制剂硝苯地平显著减弱胰蛋白酶诱导的[Ca2+]i升高。在硝苯地平存在下,LEFTY2没有进一步修饰胰蛋白酶诱导的[Ca2+]i升高。LEFTY2显著降低l型Ca2+通道水平。讨论:综上所述,我们证明高胰蛋白酶水平与阳性妊娠结局有关,不孕因子LEFTY2下调胰蛋白酶诱导的Ca2+增加,部分原因是干扰硝苯地平敏感的Ca2+进入。这些发现有助于我们进一步了解不明原因的不孕症和失败的辅助生殖技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology Biochemistry, Genetics and Molecular Biology-Cell Biology
CiteScore
9.70
自引率
3.60%
发文量
2531
审稿时长
12 weeks
期刊介绍: Frontiers in Cell and Developmental Biology is a broad-scope, interdisciplinary open-access journal, focusing on the fundamental processes of life, led by Prof Amanda Fisher and supported by a geographically diverse, high-quality editorial board. The journal welcomes submissions on a wide spectrum of cell and developmental biology, covering intracellular and extracellular dynamics, with sections focusing on signaling, adhesion, migration, cell death and survival and membrane trafficking. Additionally, the journal offers sections dedicated to the cutting edge of fundamental and translational research in molecular medicine and stem cell biology. With a collaborative, rigorous and transparent peer-review, the journal produces the highest scientific quality in both fundamental and applied research, and advanced article level metrics measure the real-time impact and influence of each publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信